Adlai Nortye - Proyeksi bathi mangsa ngarep ANL

Logo perusahaan publik Adlai Nortye Ltd. (ANL)

The expected financial result for Adlai Nortye Ltd. (ANL) on the GURU.Markets chart demonstrates the current level of the indicator. Adlai Nortye Ltd. is building a global network of oncology innovations by creating unique tumor therapy protocols. Process robotization and Big Data accelerate biomarker analysis, minimizing routine tasks. High laboratory equipment standards and reserved capacities guarantee strict adherence to development schedules for new drugs.

ANL - Proyeksi bathi mangsa ngarep Adlai Nortye Limited ing rentang 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan Adlai Nortye Ltd (ANL)

Analisis dhasar perusahaan:Adlai Nortye Limited, ANL
Produk dadi Adlai Nortye

The investor assesses Adlai Nortye Ltd. (ANL) as a high-risk biotech asset with an uncertain market entry. This metric measures the consensus expected profit, adjusted for past distortions, to test the business's resilience to shocks. An analysis of the company's net income forecast allows for tracking the impact of regulatory barriers between the US and China on capitalization. High costs for oncology drugs make this indicator a critical sensor for the cash burn rate. The long-term trend determines the viability of hypothetical commercial plans.

Perusahaan pesaing

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake